View Full Version : Researchers Fail to Reveal Full Drug Pay


hollyduck
06-08-08, 07:42 AM
A troubling story from the NYT, especially since one of the doctors discussed, Timothy E. Wilens, MD, had a very useful and comprehensive Medscape lecture this spring on adult ADHD, Clinical Cases in ADHD: Spanning the Spectrum from Adolescence to Adulthood- Medscape (http://www.addforums.com/forums/showthread.php?t=51119) Once again the direct conflict between effective medication versus big, fat profits, and distorted by insufficient support for independent researchers, muddies the waters and makes it harder for patients and parents to make informed decisions, and easier for the deniers to make our lives difficult. --Ducky
===============

Researchers Fail to Reveal Full Drug Pay (http://www.nytimes.com/2008/06/08/us/08conflict.html?_r=1&th&emc=th&oref=slogin)

A world-renowned Harvard child psychiatrist whose work has helped fuel an explosion in the use of powerful antipsychotic medicines in children earned at least $1.6 million in consulting fees from drug makers from 2000 to 2007 but for years did not report much of this income to university officials, according to information given Congressional investigators.

Senator Charles E. Grassley pushed three experts in child psychiatry at Harvard to expose their income from consulting fees.

Dr. Joseph Biederman belatedly reported at least $1.6 million in consulting fees.

By failing to report income, the psychiatrist, Dr. Joseph Biederman, and a colleague in the psychiatry department at Harvard Medical School, Dr. Timothy E. Wilens, may have violated federal and university research rules designed to police potential conflicts of interest, according to Senator Charles E. Grassley, Republican of Iowa...

[more] (http://www.nytimes.com/2008/06/08/us/08conflict.html?_r=1&th&emc=th&oref=slogin)

theta
06-08-08, 12:43 PM
A world-renowned Harvard child psychiatrist whose work has helped fuel an explosion in the use of powerful antipsychotic medicines in children earned at least $1.6 million in consulting fees from drug makers from 2000 to 2007 but for years did not report much of this income to university officials, according to information given Congressional investigators.


Thats interesting too lazy to look it all up again but it was a common suggestion that people on the autism spectrum to try/use a low dose of some
atypical antipsychotics. But the study It all seemd to be based on was a very bad study. And you would be hard press to find anyone self-reporting that
it was helpfull. More likely saying they became fat and tired. I will have to look into it when I get the energy.

First look I see his name starts in pubmed on Jan. 2002. No I can click on his name and see studies back to 1976 for a "J Biederman". I do not think he was the person behind the risperidone/autism "study".

QueensU_girl
06-08-08, 01:02 PM
He's a big name in ADD research. I'm pretty disappointed.

theta
06-08-08, 01:19 PM
I use to post entire abstracts with the authors name and a search of the forum I only see one thread were I quote abstracts with his name.

http://www.addforums.com/forums/showthread.php?t=42484&highlight=Biederman&page=2

One other one:

http://www.addforums.com/forums/showthread.php?t=52348&highlight=Biederman

TygerSan
06-09-08, 12:29 PM
This is an embarrassment! Biederman's a big name in child psychiatry in general and ADHD research specifically. Sadly, this type of thing tends tar all scientists with the same brush.

FYI, Biederman has been instrumental in getting childhood bipolar disorder recognized as a legitimate condition, but has also been quite controversial in that he advocates treating at-risk kids before they have their first "episode." [I saw this in a Frontline documentary on psych meds in children, but haven't been able to verify with quick google searching].

Sadly, his deep ties to industry and reluctance to disclose makes it easier for people to question his motives for early medication.